Loading…

Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes

Saved in:

Bibliographic Details
Published in:	Diabetic medicine 2017-04, Vol.34 (4), p.591-592
Main Authors:	Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L., Raalte, D. H.
Format:	Article
Language:	English
Subjects:	Aged Amylases - blood Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - enzymology Exenatide Glucagon-Like Peptide-1 Receptor - agonists Humans Hypoglycemic Agents Letter Letters Lipase - blood Middle Aged Peptides - adverse effects Peptides - therapeutic use Randomized Controlled Trials as Topic Venoms - adverse effects Venoms - therapeutic use
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!